Quanterix Corporation header image

Quanterix Corporation

QTRX

Equity

ISIN null / Valor 39127916

NASDAQ (2026-04-10)
USD 3.36+1.82%

Quanterix Corporation
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Quanterix Corporation is a company focused on transforming healthcare by enhancing the precision and understanding of health to disease progression through advanced scientific research. It operates at the forefront of the healthcare industry, leveraging a combination of experienced management, leading scientists, and strategic investments to push the boundaries of precision health science. The company has established a significant global presence, serving hundreds of academic and industry clients with direct sales in North America and parts of Europe, while also reaching a wider international market through distributor partnerships. Quanterix offers a range of products and services designed to support the research needs of its customers, backed by a dedicated team of field application scientists and engineers providing comprehensive customer support worldwide. This approach underscores the company's commitment to advancing healthcare research and diagnostics through innovative technology and collaborative efforts.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-30.1%1Y
-73.7%3Y
-94.9%5Y

Performance

82.4%1Y
73.2%3Y
82.5%5Y

Volatility

Market cap

158 M

Market cap (USD)

Daily traded volume (Shares)

677,893

Daily traded volume (Shares)

1 day high/low

11.04 / 10.715

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Staar Surgical Co
Staar Surgical Co Staar Surgical Co Valor: 972813
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.88%USD 26.44
Takeda Yakuhin Kogyo KK
Takeda Yakuhin Kogyo KK Takeda Yakuhin Kogyo KK Valor: 11292411
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.06%USD 18.08
Quest Diagnostics Inc
Quest Diagnostics Inc Quest Diagnostics Inc Valor: 566162
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.19%USD 191.51
Hims & Hers Health Inc
Hims & Hers Health Inc Hims & Hers Health Inc Valor: 59397181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.62%USD 19.43
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.09%EUR 43.95
Premier Inc
Premier Inc Premier Inc Valor: 22227168
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 28.26
Amicus Therapeutics Inc
Amicus Therapeutics Inc Amicus Therapeutics Inc Valor: 2644388
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.07%USD 14.46
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.16%CHF 91.35
Fagron SA
Fagron SA Fagron SA Valor: 3425437
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 22.50
Coloplast A/S
Coloplast A/S Coloplast A/S Valor: 20259063
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.76%DKK 428.50